IBD
97
16
18
31
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.2%
6 terminated out of 97 trials
83.8%
-2.7% vs benchmark
8%
8 trials in Phase 3/4
19%
6 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 31 completed trials
Clinical Trials (97)
Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA
Impact of IBD Activity on Frailty in Patients Over 60 Years
Adjunctive Treatment With Vitamin D3 in Patients With Active IBD
Immunological Characteristics of Preclinical IBD
A Randomised Paired Design Study of Texture and Colour Enhancement Imaging (TXI) Versus High-definition White Light Endoscopy
Open-label Extension Study of Brazikumab in Crohn's Disease
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
The Assessment of Infrared Treatment for Crohn's Disease
Validation of PET Questionnaire for Experience and Sustainability in Telemedicine. PET(Patient Experience in Telehealth)
Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease
Pregnancy and Inflammatory Bowel Disease
Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.
Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease
Evaluation of the SMART IBD App in Pediatric IBD
Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
Texture and Colour Enhancement Imaging (TXI) Versus Dye Chromoendoscopy for Dysplasia Detection in IBD Surveillance.
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
SMART-IBD App Trial
Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD